• 1
    Sakaguchi S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000; 101: 4558.
  • 2
    Shevach EM. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002; 2: 389400.
  • 3
    Read S, Powrie F. CD4 (+) regulatory T cells. Curr Opin Immunol 2001; 13: 6449.
  • 4
    Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 16416.
  • 5
    Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199210.
  • 6
    Thorstenson KM, Khoruts A. Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 2001; 167: 18895.
  • 7
    Hara M, Kingsley CI, Niimi M. et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 2001; 166: 378996.
  • 8
    Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999; 190: 9951004.
  • 9
    Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA. A role for TGF-beta in the generation and expansion of CD4(+) CD25(+) regulatory T cells from human peripheral blood. J Immunol 2001; 166: 72829.
  • 10
    Liu H, Hu B, Xu D, Liew FY. CD4+CD25+ regulatory T cells cure murine colitis. the role of IL-10, TGF-beta, and CTLA4. J Immunol 2003; 171: 501217.
  • 11
    Nakamura K, Kitani A, Fuss I, Pedersen A, Harada N, Nawata H, Strober W. TGF-beta1 plays an amportant role in the mechanism of CD4(+) CD25(+) regulatory T cell activity in both humans and mice. J Immunol 2004; 172: 83442.
  • 12
    Chen W, Jin W, Hardegen N. et al. Conversion of peripheral CD4+CD25– naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 2003; 198: 187586.
  • 13
    Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK. Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003; 198: 24958.
  • 14
    Khattri R, Cox T, Yasayko SA, Ramsdell F. An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 2003; 4: 33742.
  • 15
    Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 2003; 4: 3306.
  • 16
    Sacks G, Sargent I, Redman C. An innate view of human pregnancy. Immunol Today 1999; 20: 11418.
  • 17
    Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, Munn DH. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nat Immunol 2001; 2: 648.
  • 18
    Munn DH, Zhou M, Attwood JT. et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 11913.
  • 19
    Kudo Y, Boyd CA, Sargent IL, Redman CW. Tryptophan degradation by human placental indoleamine 2,3-dioxygenase regulates lymphocyte proliferation. J Physiol 2001; 535: 20715.
  • 20
    Grohmann U, Orabona C, Fallarino F. et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3: 1097101.
  • 21
    Fallarino F, Grohmann U, Hwang KW. et al. Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 2003; 4: 120612.
  • 22
    Hewison M, Freeman L, Hughes SV. et al. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170: 538290.
  • 23
    Sebastiani S, Allavena P, Albanesi C. et al. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity. J Immunol 2001; 166: 9961002.
  • 24
    Pijnenborg R, Bland JM, Robertson WB, Brosens I. Uteroplacental arterial changes related to interstitial trophoblast migration in early human pregnancy. Placenta 1983; 4: 397413.
  • 25
    Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus. A prospective study of 103 pregnancies. Rheumatology (Oxford) 2002; 41: 64350.
  • 26
    Thurnau GR. Rheumatoid arthritis. Clin Obstet Gynecol 1983; 26: 55878.
  • 27
    Friberg M, Jennings R, Alsarraj M. et al. Indoleamine 2,3-dioxygenase contributes to tumor cell evasion of T cell- mediated rejection. Int J Cancer 2002; 101: 1515.
  • 28
    Schrocksnadel K, Widner B, Bergant A, Neurauter G, Schennach H, Schrocksnadel H, Fuchs D. Longitudinal study of tryptophan degradation during and after pregnancy. Life Sci 2003; 72: 78593.
  • 29
    Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 26671.